216 related articles for article (PubMed ID: 11705894)
1. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
Narum DL; Kumar S; Rogers WO; Fuhrmann SR; Liang H; Oakley M; Taye A; Sim BK; Hoffman SL
Infect Immun; 2001 Dec; 69(12):7250-3. PubMed ID: 11705894
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
3. Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization.
Wang L; Menting JG; Black CG; Stowers A; Kaslow DC; Hoffman SL; Coppel RL
Vaccine; 2000 Nov; 19(7-8):816-24. PubMed ID: 11115704
[TBL] [Abstract][Full Text] [Related]
4. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
[TBL] [Abstract][Full Text] [Related]
5. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems.
Yadava A; Ockenhouse CF
Infect Immun; 2003 Sep; 71(9):4961-9. PubMed ID: 12933838
[TBL] [Abstract][Full Text] [Related]
6. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
[TBL] [Abstract][Full Text] [Related]
7. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Saul A
J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
[No Abstract] [Full Text] [Related]
8. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
9. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
Hedstrom RC; Doolan DL; Wang R; Kumar A; Sacci JB; Gardner MJ; Aguiar JC; Charoenvit Y; Sedegah M; Tine JA; Margalith M; Hobart P; Hoffman SL
Int J Mol Med; 1998 Jul; 2(1):29-38. PubMed ID: 9854139
[TBL] [Abstract][Full Text] [Related]
10. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
[TBL] [Abstract][Full Text] [Related]
11. Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture.
Jones TR; Gramzinski RA; Aguiar JC; Sim BK; Narum DL; Fuhrmann SR; Kumar S; Obaldia N; Hoffman SL
Vaccine; 2002 Feb; 20(11-12):1675-80. PubMed ID: 11858878
[TBL] [Abstract][Full Text] [Related]
12. Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.
Regis DP; Dobaño C; Quiñones-Olson P; Liang X; Graber NL; Stefaniak ME; Campo JJ; Carucci DJ; Roth DA; He H; Felgner PL; Doolan DL
Mol Biochem Parasitol; 2008 Mar; 158(1):32-45. PubMed ID: 18164079
[TBL] [Abstract][Full Text] [Related]
13. Malaria DNA vaccines in Aotus monkeys.
Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
Iyori M; Nakaya H; Inagaki K; Pichyangkul S; Yamamoto DS; Kawasaki M; Kwak K; Mizukoshi M; Goto Y; Matsuoka H; Matsumoto M; Yoshida S
PLoS One; 2013; 8(8):e70819. PubMed ID: 23951015
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.
Datta D; Bansal GP; Gerloff DL; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2017 Jan; 35(2):264-272. PubMed ID: 27912985
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.
Kocken CH; Withers-Martinez C; Dubbeld MA; van der Wel A; Hackett F; Valderrama A; Blackman MJ; Thomas AW
Infect Immun; 2002 Aug; 70(8):4471-6. PubMed ID: 12117958
[TBL] [Abstract][Full Text] [Related]
17. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
[TBL] [Abstract][Full Text] [Related]
18. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
Ballou WR; Kester KE; Heppner DG
Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
[No Abstract] [Full Text] [Related]
19. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.
Wang R; Doolan DL; Charoenvit Y; Hedstrom RC; Gardner MJ; Hobart P; Tine J; Sedegah M; Fallarme V; Sacci JB; Kaur M; Klinman DM; Hoffman SL; Weiss WR
Infect Immun; 1998 Sep; 66(9):4193-202. PubMed ID: 9712767
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
